U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

Results: 1 to 20 of 21

Tests names and labsConditionsGenes, analytes, and microbesMethods

Efavirenz central nervous system toxicity, susceptibility to, 614546 (Efavirenz toxicity) (MLPA)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • D Deletion/duplication analysis

Efavirenz, poor metabolism of, 614546 (Efavirenz toxicity) (CYP2B6 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Efavirenz central nervous system toxicity, susceptibility to, 614546 (Efavirenz toxicity) (CYP2B6 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Efavirenz, poor metabolism of, 614546 (Efavirenz toxicity) (MLPA)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • D Deletion/duplication analysis

Precision HealthPGx Panel (25 Genes)

RPRD Diagnostics, LLC
United States
9723
  • D Deletion/duplication analysis
  • T Targeted variant analysis

Admera Health PGxOne™ Plus

Admera Health
United States
9916
  • T Targeted variant analysis

Whole Pharmacogenomics Scan

RPRD Diagnostics, LLC
United States
10769
  • D Deletion/duplication analysis
  • T Targeted variant analysis

Comprehensive PGx Panel

Dynamic DNA Laboratories, LLC
United States
12518
  • D Deletion/duplication analysis
  • T Targeted variant analysis

Gravity Pharmacogenetics Comprehensive Profile

Gravity Diagnostics
United States
8617
  • T Targeted variant analysis

CYP2B6 Genotype

Mayo Clinic Laboratories Mayo Clinic
United States
71
  • T Targeted variant analysis

Rxight Pharmacogenetics Program

MD Labs
United States
628
  • T Targeted variant analysis

CYP2B6-Related Disorders via the CYP2B6 Gene

PreventionGenetics, part of Exact Sciences
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CYP2B6 (CYP2B6 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Pharmacogenomics Test Panel

IU Genetic Testing Laboratories Indiana University School of Medicine
United States
813
  • T Targeted variant analysis

CYP2B6 Genotyping

IU Genetic Testing Laboratories Indiana University School of Medicine
United States
11
  • T Targeted variant analysis

CYP2B6

ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories
United States
41
  • T Targeted variant analysis

CYP2B6 genotyping

Sinochips Diagnostics
United States
31
  • T Targeted variant analysis

Susceptibility to Drugs (Efavirenz) , Sequencing CYP2B6 Gene

Reference Laboratory Genetics
Spain
11
  • C Sequence analysis of the entire coding region

Pharmacogenetic panel

Diagnosticum Center for Human Genetics
Germany
4629
  • T Targeted variant analysis

CYP2B6

MVZ Dr. Eberhard & Partner Dortmund
Germany
11
  • E Sequence analysis of select exons

Results: 1 to 20 of 21

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.